Stephen Joyce
Corporate Officer/Principal at GAMIDA CELL LTD.
Profile
Stephen Joyce is currently the SVP, Head-Marketing & Corporate Communications at Amryt Pharma Plc and the Chief Business Officer at Gamida Cell Ltd.
Previously, he worked as the Director-Area Marketing & Market Access at Astellas Pharma Europe Ltd.
from 2016 to 2018.
He also held the position of SVP, Head-Marketing & Corporate Communications at Amryt Pharma Holdings Ltd.
Additionally, he served as the General Manager-Switzerland at Astellas Pharmaceuticals AG in 2018.
Mr. Joyce completed his undergraduate degree at Trinity College Dublin.
Stephen Joyce active positions
Companies | Position | Start |
---|---|---|
GAMIDA CELL LTD. | Corporate Officer/Principal | - |
Former positions of Stephen Joyce
Companies | Position | End |
---|---|---|
AMRYT PHARMA PLC | Public Communications Contact | 30/04/2023 |
Astellas Pharmaceuticals AG | Corporate Officer/Principal | 31/10/2018 |
Astellas Pharma Europe Ltd.
Astellas Pharma Europe Ltd. Pharmaceuticals: MajorHealth Technology Astellas Pharma Europe Ltd. engages in the development and sale of pharmaceutical products. The company is headquartered in Addlestone, the United Kingdom. | Corporate Officer/Principal | 31/12/2017 |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Public Communications Contact | - |
Training of Stephen Joyce
Trinity College Dublin | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
GAMIDA CELL LTD. | Health Technology |
Private companies | 4 |
---|---|
Astellas Pharma Europe Ltd.
Astellas Pharma Europe Ltd. Pharmaceuticals: MajorHealth Technology Astellas Pharma Europe Ltd. engages in the development and sale of pharmaceutical products. The company is headquartered in Addlestone, the United Kingdom. | Health Technology |
Amryt Pharma Holdings Ltd.
Amryt Pharma Holdings Ltd. Pharmaceuticals: MajorHealth Technology Amryt Pharma Holdings Ltd. is a pharmaceutical company, which engages in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. Its products include Lomitapide and Metreleptin. The Lomitapide provides homozygous familial hypercholesterolemia (HoFH), and Metreleptin provides treatment for generalized lipodystrophy (GL) and partial lipodystrophy (PL). The company was founded on December 20, 2004 and is headquartered in London, the United Kingdom. | Health Technology |
Amryt Pharma Plc
Amryt Pharma Plc Pharmaceuticals: MajorHealth Technology Amryt Pharma Plc operates as a holding company with interests in the development and delivery of treatments to help improve the lives of patients with rare and orphan diseases. The company was founded on July 17, 2019 and is headquartered in Dublin, Ireland. | Health Technology |
Astellas Pharmaceuticals AG |
- Stock Market
- Insiders
- Stephen Joyce